Ascendis Pharma A/S (NASDAQ:ASND)

Delayed Data
As of Dec 08
 -0.92 / -0.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Ascendis Pharma A/S have a median target of 142.85, with a high estimate of 198.28 and a low estimate of 110.90. The median estimate represents a +32.41% increase from the last price of 107.88.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Ascendis Pharma A/S. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.69%
Growthannually 5.90%


Growthquarterly 5.83%
Growthannually 231.14%
Key to the earnings and sales forecast charts.